HEPATITIS C
•Download as PPT, PDF•
0 likes•653 views
This document discusses Hepatitis C, including its definition, signs and symptoms, risk factors, disease management, nursing interventions, and screening guidelines. It notes that Hepatitis C is the most common bloodborne infection in the US, infecting approximately 3.2 million people chronically. Nursing strategies aim to educate patients, monitor for drug and alcohol use, and encourage vaccination against Hepatitis A and B. Screening guidelines recommend testing all at-risk patients and those with liver illness symptoms over 6 months.
Report
Share
Report
Share
![Introduction ,[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Between Facts and Voices: Medical and Lay Knowledge of the Spread of Hepatitis C
Dissertation Defense slides for Adam T. Perzynski, PhD
Defended in 2008 at Department of Sociology, Case Western Reserve University
HIV discrimination among health providers in Malaysia by Dr Rubz
Although doctors took oath that they will treat everyone the best they can and without judging anyone but discrimination still exist especially in HIV affected people. Due to this issue, Pertubuhan Advokasi Masyarakat Terpinggir Malaysia has taken a step to engage with doctors at government sector and desensitize them and find the line to stand together.
The what, the why, and the how og lipoatrophy in hiv
Esta presentación se centra en la pérdida de la grasa corporal en los pacientes con VIH, lo que se conoce como lipoatrofia.
Pulmonary Fibrosis Patient/Caregiver Experience Survey
The "Pulmonary Fibrosis Patient/Caregiver Experience Survey" explored the experiences of people affected by pulmonary fibrosis. Inspire conducted the survey in cooperation with its partner, the Pulmonary Fibrosis Foundation (PFF). Inspire CEO Brian Loew presented the findings during the PFF Summit in Nov. 2015 in Washington, DC.
Comparison of HIV Testing with other Markers of Chronic Disease Screening
Comparison of HIV Testing with other Markers of Chronic Disease Screening Leonard Davis Institute of Health Economics
Final reproductive tract infectionspdf
WHO statistics indicate that Over 340 million curable and many
more incurable STIs occur each year among women worldwide and that
Non-sexually-transmitted RTIs are even more common. Failure to diagnose
and treat STIs/RTIs at an early stage may result into serious complications
and consequences including infertility, fetal wastage, ectopic pregnancy,
anogenital cancer, premature delivery, as well as neonatal and infant
infections. Proper management of STIs/RTIs also reduce the maternal and
infant mortality. STIs are also known to enhance the spread of HIV infection
in communities. STIs/ RTIs also have negative socio economic impact that
include, increase cost for health service, relationship/ marriage problems
etc.
Recommended
Between Facts and Voices: Medical and Lay Knowledge of the Spread of Hepatitis C
Dissertation Defense slides for Adam T. Perzynski, PhD
Defended in 2008 at Department of Sociology, Case Western Reserve University
HIV discrimination among health providers in Malaysia by Dr Rubz
Although doctors took oath that they will treat everyone the best they can and without judging anyone but discrimination still exist especially in HIV affected people. Due to this issue, Pertubuhan Advokasi Masyarakat Terpinggir Malaysia has taken a step to engage with doctors at government sector and desensitize them and find the line to stand together.
The what, the why, and the how og lipoatrophy in hiv
Esta presentación se centra en la pérdida de la grasa corporal en los pacientes con VIH, lo que se conoce como lipoatrofia.
Pulmonary Fibrosis Patient/Caregiver Experience Survey
The "Pulmonary Fibrosis Patient/Caregiver Experience Survey" explored the experiences of people affected by pulmonary fibrosis. Inspire conducted the survey in cooperation with its partner, the Pulmonary Fibrosis Foundation (PFF). Inspire CEO Brian Loew presented the findings during the PFF Summit in Nov. 2015 in Washington, DC.
Comparison of HIV Testing with other Markers of Chronic Disease Screening
Comparison of HIV Testing with other Markers of Chronic Disease Screening Leonard Davis Institute of Health Economics
Final reproductive tract infectionspdf
WHO statistics indicate that Over 340 million curable and many
more incurable STIs occur each year among women worldwide and that
Non-sexually-transmitted RTIs are even more common. Failure to diagnose
and treat STIs/RTIs at an early stage may result into serious complications
and consequences including infertility, fetal wastage, ectopic pregnancy,
anogenital cancer, premature delivery, as well as neonatal and infant
infections. Proper management of STIs/RTIs also reduce the maternal and
infant mortality. STIs are also known to enhance the spread of HIV infection
in communities. STIs/ RTIs also have negative socio economic impact that
include, increase cost for health service, relationship/ marriage problems
etc.
Patient-centric social media for outcomes and pharmacovigilance consideration...
Through the use of de-identified Big Data from online patient forums open to healthcare providers, the pharmaceutical industry may glean useful insights into both the safety of existing products as well as future needs of patients. Post-marketing safety surveillance for pharmaceuticals currently relies on data from adverse event reports to companies or regulatory authorities, medical literature, and observational databases. Together these sources provide some insight into everyday product safety or risk, but the unique insight the patients themselves can offer is also highly desirable.
Using insights from a 2016 research project involving Inspire, GlaxoSmithKline (GSK) Pharmaceuticals, and Epidemico, an innovative informatics company, we are exploring the use of social listening data for pharmacovigilance and other R&D concerns. A core question is, “What valuable insights can we glean from social listening to help improve patients’ lives—whether through improved safety, more relevant clinical trials, or research and development of new treatment options?”
Carle Palliative Care Journal Club 1/15/2020
A journal club review and criticism of J Natl Cancer Inst. 2019 Dec 17. pii: djz233. doi: 10.1093/jnci/djz233 Emergency Department Visits for Opioid Overdoses Among Patients with Cancer by Jairam V, Yang DX, Yu JB, Park HS.
Carle Palliative Care Journal Club for 7/3/18
Journal club review of "Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial" by D. Hui et. al. in JAMA. 2017 Sep 19;318(11):1047-1056.
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
Contact for more presentations on +91-8741095005
WHO: Preventive Program and Chemical Substance Safety
Title: Safeguarding Health: WHO Preventive Program and Chemical Substance Safety
Description:
This presentation sheds light on the World Health Organization's (WHO) impactful Preventive Program, focusing on the vital aspect of chemical substance safety. Uncover the global initiatives and guidelines implemented by WHO to protect public health from potential hazards associated with chemical exposure. Explore the comprehensive strategies aimed at preventing chemical-related illnesses and promoting safety across diverse industries. Delve into the importance of regulatory frameworks, risk assessments, and international cooperation in ensuring the safe handling, usage, and disposal of chemical substances. Join us in understanding how WHO plays a pivotal role in championing a healthier, safer world through proactive preventive measures and robust chemical substance safety protocols.
1770 Embracing Diversity and Inclusion in Clinical Trials-Presented by Abbott...
1770 Embracing Diversity and Inclusion in Clinical Trials-Presented by Abbott...Career Communications Group
The concept is at the very core of everything we do: the best health care products are those that help the most people by providing the greatest benefit. Those products should result from clinical trials that include the diverse and representative populations who need them most. It sounds simple, but it’s not. The fact is that while people of diverse ethnic and cultural backgrounds make up nearly 40% of the U.S. population -- and are disproportionally impacted by chronic conditions like diabetes and cardiovascular disease, they are still heavily under-represented in the clinical trials process. Women are likewise under-represented.
These gaps exacerbate existing health equity challenges by curbing access to life-changing and life-saving treatments for some, while limiting insights into how different groups respond to new therapies. So we are doing something to close those gaps. Right now. By launching an initiative to drive diversity in research and improve care among under-represented populations, we are working to advance health equity and make access a crucial aspect of product innovation, two key aspects of Abbott's 2030 Sustainability Program. The medical therapies we develop can only be as strong and inclusive as the people who design, develop and participate in our clinical trials. Their involvement will benefit all.
ROJoson PEP Talk: Liver Cancer and Viral Hepatitis Awareness
ROJoson PEP Talk: Liver Cancer and Viral Hepatitis Awareness - 2023
More Related Content
What's hot
Patient-centric social media for outcomes and pharmacovigilance consideration...
Through the use of de-identified Big Data from online patient forums open to healthcare providers, the pharmaceutical industry may glean useful insights into both the safety of existing products as well as future needs of patients. Post-marketing safety surveillance for pharmaceuticals currently relies on data from adverse event reports to companies or regulatory authorities, medical literature, and observational databases. Together these sources provide some insight into everyday product safety or risk, but the unique insight the patients themselves can offer is also highly desirable.
Using insights from a 2016 research project involving Inspire, GlaxoSmithKline (GSK) Pharmaceuticals, and Epidemico, an innovative informatics company, we are exploring the use of social listening data for pharmacovigilance and other R&D concerns. A core question is, “What valuable insights can we glean from social listening to help improve patients’ lives—whether through improved safety, more relevant clinical trials, or research and development of new treatment options?”
Carle Palliative Care Journal Club 1/15/2020
A journal club review and criticism of J Natl Cancer Inst. 2019 Dec 17. pii: djz233. doi: 10.1093/jnci/djz233 Emergency Department Visits for Opioid Overdoses Among Patients with Cancer by Jairam V, Yang DX, Yu JB, Park HS.
Carle Palliative Care Journal Club for 7/3/18
Journal club review of "Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial" by D. Hui et. al. in JAMA. 2017 Sep 19;318(11):1047-1056.
What's hot (10)
Patient-centric social media for outcomes and pharmacovigilance consideration...
Patient-centric social media for outcomes and pharmacovigilance consideration...
Similar to HEPATITIS C
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
Contact for more presentations on +91-8741095005
WHO: Preventive Program and Chemical Substance Safety
Title: Safeguarding Health: WHO Preventive Program and Chemical Substance Safety
Description:
This presentation sheds light on the World Health Organization's (WHO) impactful Preventive Program, focusing on the vital aspect of chemical substance safety. Uncover the global initiatives and guidelines implemented by WHO to protect public health from potential hazards associated with chemical exposure. Explore the comprehensive strategies aimed at preventing chemical-related illnesses and promoting safety across diverse industries. Delve into the importance of regulatory frameworks, risk assessments, and international cooperation in ensuring the safe handling, usage, and disposal of chemical substances. Join us in understanding how WHO plays a pivotal role in championing a healthier, safer world through proactive preventive measures and robust chemical substance safety protocols.
1770 Embracing Diversity and Inclusion in Clinical Trials-Presented by Abbott...
1770 Embracing Diversity and Inclusion in Clinical Trials-Presented by Abbott...Career Communications Group
The concept is at the very core of everything we do: the best health care products are those that help the most people by providing the greatest benefit. Those products should result from clinical trials that include the diverse and representative populations who need them most. It sounds simple, but it’s not. The fact is that while people of diverse ethnic and cultural backgrounds make up nearly 40% of the U.S. population -- and are disproportionally impacted by chronic conditions like diabetes and cardiovascular disease, they are still heavily under-represented in the clinical trials process. Women are likewise under-represented.
These gaps exacerbate existing health equity challenges by curbing access to life-changing and life-saving treatments for some, while limiting insights into how different groups respond to new therapies. So we are doing something to close those gaps. Right now. By launching an initiative to drive diversity in research and improve care among under-represented populations, we are working to advance health equity and make access a crucial aspect of product innovation, two key aspects of Abbott's 2030 Sustainability Program. The medical therapies we develop can only be as strong and inclusive as the people who design, develop and participate in our clinical trials. Their involvement will benefit all.
ROJoson PEP Talk: Liver Cancer and Viral Hepatitis Awareness
ROJoson PEP Talk: Liver Cancer and Viral Hepatitis Awareness - 2023
Running head Community Teaching Work Plan ProposalPrimary Pre.docx
Running head: Community Teaching Work Plan Proposal
Primary Prevention of Heart Disease/Cardiovascular Disease.
Name and Credentials of Teacher
Estimated Time Teaching Will Last:
1hour 30 minutes.
Location of Teaching:
Group home
Supplies, Material, Equipment Needed:
Laptop, Snacks and drinks
Estimated Cost: $25
Community and Target Aggregate:
Young adults of 25-38 years
Topic:
Risks and Prevention of Heart Disease/Cardiovascular Disease.
Identification of Focus for Community Teaching (Topic Selection):The topic of focus for community focus is the risks and prevention of heart diseases.
Epidemiological Rationale for Topic (Statistics Related to Topic):
Cardiovascular disease is one of the major causes of deaths globally. Heart disease is a collection of diseases that affect the heart. Under this spectrum, some diseases include blood vessel diseases like heart defects from birth (congenital heart defects), coronary artery disease, and heart rhythm conditions (arrhythmia), etc. Around 600,000 people die of cardiovascular disease in the US each year (WHO, 2017). It is considered as the biggest cause of death for both women and men. Coronary heart disease is the prevalent type heart disease, claiming around 370,000 lives every year. Each year, around 750,000 Americans develop heart attack (Allender, Peto & Scarborough, 2017). Around 42% of those diagnosed with heart disease are between ages 25-38. Smoking, high cholesterol, and high blood pressure are key risk factors that increases the risk of contracting heart disease.
In my county, Middlesex, New jersey despite an 11% decline between 2010 (174.4/100,000) and 2014 (155.2/100,000) and a top 25% statewide ranking, deaths due to heart disease perform lower than the Healthy People 2020 target (108.8/100,000) by 42.6%. The 2014 Middlesex County mortality rate due to heart disease (155.2/100,000) is 6.2% lower than Statewide (165.4/100,000) and is similar to neighboring Union and Monmouth Counties. Across all race/ethnicities, the Middlesex County death rate for heart disease improves from 2010 through 2014. In 2014, the Middlesex County heart disease mortality rate for Whites (176.2/100,000) is similar to New Jersey (173.4/100,000). Within the County, Whites have the highest heart disease mortality rate as compared to statewide statistics in which Blacks (191.2/100,000) have the highest rate. Between 2009 and 2015, Middlesex County adults who are told they have high blood pressure increased from 27.5% to 29.2% which exceeds the Healthy People 2020 target (26.9%) for adults with high blood pressure (Hackensack Meridian Health, 2017).
Nursing Diagnosis:
Deficient knowledge regarding heart disease related to incomplete information as evidenced by request for information/verbalization of concerns and misconception.
Readiness for Learning: Identify the factors that would indicate the readiness to learn for the target aggregate. Include emotional and experiential readiness to learn.
One of the ...
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Pre-Exposure Prophylaxis for HIV Infection, is it Working? by Junior Bazile in Perceptions in Reproductive Medicine
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
Why, When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
The Impact of Patients’ Disease-Labels on Disease Experience Living Longer ...
Advances in oncology have resulted in prolonged disease trajectories, also for patients with incurable cancer. This has induced discussions about the ‘right’ medical terminology. The impact of choosing a specific disease-label on well-being can be high.
The Impact of Patients’ Disease-Labels on Disease Experience Living Longer ...
Advances in oncology have resulted in prolonged disease trajectories, also for patients with incurable cancer. This has induced discussions about the ‘right’ medical terminology. The impact of choosing a specific disease-label on well-being can be high.
Running head TUBERCULOSIS .docx
Running head: TUBERCULOSIS 1
TUBERCULOSIS 2
Tuberculosis
NRS-427VN | Epidemiology and Communicable Disease
8/26/18
Tuberculosis
About 33% in our existence's people is considered to have been tainted with tuberculosis (TB), new attacks are symbolized in no under 1% of the people every year". In 2016, a standard 1.5 million fatalities associated with TB have took place, the lion's talk about which are from younger looking countries over the world. As this quantity has been reducing, unnecessarily various have been sullied. The best center is situated in the Asian and African countries, at 80%. Within the USA, 5-10% of the individuals studies constructive. With tuberculosis taking after second behind HIV/Helps in most common deaths from powerful ailment, they have transformed into an over-all exchange. Understanding the annals, seeing the signals and appearances, evolved treatment alternatives, and neutralizing activity, will spread this disease to an even of control.
Since the start, tuberculosis has been accessible. Most quick unambiguous affirmation of the malady has been dated around 17,000 years before, in stays of a bison in Wyoming. Effective treatment of tuberculosis has finished up being bothersome and long. Chemical manifestations of the mycobacterium cell dividers and bizarre form, restricts most against microbial alternatives. Most typically used is Isoniazid and Rifampicin. Advised estimations of treatment, for new starting point, are half a year of blend hostile to infections operators. 8 weeks of rifampicin, isoniazid, pyrazinamide, and ethambutol drugs. Together with the latest four a few months of just rifampicin and isoniazid"(Wikipedia, 2015, p. 12).For the individuals who have idle TB receive only a sole against microbial.
This estimation ruins the inert TB to wrap up aspect. As this move out estimations of hostile to infections specialists can be difficult, direct observed treatment is preferred by WHO (World Health Corporation, 2015). Facts have exhibited that folks, who are depended after to adopt their medicine, will miss organized estimations. Immediate discernment treatment contains having an interpersonal protection employee watch the individual taking their remedies. As this is dreary, using diverse contraptions of acknowledgment is necessary. Such overhauls can sign up for booked calls or digital notices. By not doing medication regimens, put others at peril to finding this sickness.
Those in close closeness to specific with tuberculosis are in an especially high danger to finding the opportunity to be debased. Besides, with HIV/Supports hold the most hoisted risk element of all. Early on area and treatment, with fitted hindrances of these polluted is an integral.
Friendly determinants ...
Similar to HEPATITIS C (20)
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
Epidemiology of periodontal diseases By Dr. Abhishek Gaur (8741095005)
WHO: Preventive Program and Chemical Substance Safety
WHO: Preventive Program and Chemical Substance Safety
1770 Embracing Diversity and Inclusion in Clinical Trials-Presented by Abbott...
1770 Embracing Diversity and Inclusion in Clinical Trials-Presented by Abbott...
ROJoson PEP Talk: Liver Cancer and Viral Hepatitis Awareness
ROJoson PEP Talk: Liver Cancer and Viral Hepatitis Awareness
Running head Community Teaching Work Plan ProposalPrimary Pre.docx
Running head Community Teaching Work Plan ProposalPrimary Pre.docx
Strategies for reducing morbidity and mortality from diabetes through health
Strategies for reducing morbidity and mortality from diabetes through health
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
Crimson Publishers-Pre-Exposure Prophylaxis for HIV Infection, is it Working?
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
When, and How to Use Pre Exposure Prophylaxis for HIV Acquisition. 2014
The Impact of Patients’ Disease-Labels on Disease Experience Living Longer ...
The Impact of Patients’ Disease-Labels on Disease Experience Living Longer ...
The Impact of Patients’ Disease-Labels on Disease Experience Living Longer ...
The Impact of Patients’ Disease-Labels on Disease Experience Living Longer ...
HEPATITIS C
- 1. HEPATITIS C Teresa Pate, RN Chamberlain College of Nursing NR 305 Health Assessment Trish Whitman, MSN, RN October 17 th , 2010